These results imply that, whilst multiple downstream pathways of Src/EGFR contribute to the asthma phenotype, upstream inhibtion of Src/EGFR is more effective than selective inhibition of downstream pathways or transcriptional factors. The gene discussed is SRC; the disease is asthma.